IRVINE, Calif. (AP) Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a loss of $15.2 million in its fourth quarter. On a per-share basis, the Irvine, California-based company said it had a loss of 34 cents.
The Sacral Nerve Stimulation Market is driven by increasing cases of overactive bladder, urinary retention, and fecal incontinence. In addition, the growing adoption of minimally invasive therapies